Brief: Standard Biotools Announces Third Quarter 2022 Financial Results

Standard BioTools

08/11/2022 23:04

Nov 8 (Reuters) - Standard BioTools Inc  LAB.O :
    * STANDARD BIOTOOLS ANNOUNCES THIRD QUARTER 2022 FINANCIAL
RESULTS
    * STANDARD BIOTOOLS INC - Q3 CORE PRODUCT AND SERVICES
REVENUE
INCREASE OF 30% SEQUENTIALLY TO $24.8 MILLION
    * STANDARD BIOTOOLS INC - ON TRACK TO ACHIEVE POSITIVE FREE
CASH
FLOW BY YEAR-END 2024
    * STANDARD BIOTOOLS INC - CASH, CASH EQUIVALENTS, AND
SHORT-TERM
INVESTMENTS AS OF SEPTEMBER 30, 2022, WERE $185.2 MILLION
    * STANDARD BIOTOOLS INC - QTRLY LOSS PER SHARE $0.37

Source text for Eikon:  ID:nGNX2yClwg 
Further company coverage:  LAB.O 
 ((Reuters.Briefs@thomsonreuters.com;;))